Vaccine Technologies Against Avian Influenza: Current Approaches and New Directions

被引：9
作者：
Ross, Kathleen A. [1 ]
Huntimer, Lucas M. [2 ]
Ramirez, Julia E. Vela [1 ]
Adams, Justin R. [1 ]
Carpenter, Susan L. [3 ]
Kohut, Marian L. [4 ]
Bronich, Tatiana [5 ]
Webby, Richard [6 ]
Legge, Kevin L. [7 ]
Mallapragada, Surya K. [1 ]
Wannemuehler, Michael J. [2 ]
Narasimhan, Balaji [1 ]
机构：
[1] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA
[2] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA
[3] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA
[4] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA
[5] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA
[6] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA
[7] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA
来源：
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY | 2014年 / 10卷 / 09期
关键词：
H5N1; Highly Pathogenic Avian Influenza; Pandemic; Vaccine; Antiviral; VIRUS-LIKE-PARTICLES; T-CELL RESPONSES; REACTIVE IMMUNE-RESPONSES; PRIME-BOOST VACCINATION; AGE-RELATED DEFECTS; 2009 PANDEMIC H1N1; B SURFACE-ANTIGEN; H5N1; INFLUENZA; A H5N1; DENDRITIC CELLS;
D O I：
10.1166/jbn.2014.1983
中图分类号：
TB3 [工程材料学];
学科分类号：
0805 ; 080502 ;
摘要：
The potential epidemiological human pandemic resulting from highly pathogenic avian influenza (HPAI) H5N1 has been studied extensively since the identification of the virus in the Guangdong province of China. The majority of research has focused on the unique and severe histopathological lesions induced by the virus. The severe pathological presentation of these infections has also prompted interest in identifying preventive and therapeutic approaches against HPAI. The potential severity of a HPAI pandemic and the efforts to identify effective intervention strategies have led to many novel discoveries in vaccine and antiviral development that are critically examined in this review.
引用
收藏
页码：2261 / 2294
页数：34
相关论文
共 334 条
  • [71] Age effects on B cells and humoral immunity in humans
    Frasca, Daniela
    Diaz, Alain
    Romero, Maria
    Landin, Ana Marie
    Blomberg, Bonnie B.
    [J]. AGEING RESEARCH REVIEWS, 2011, 10 (03) : 330 - 335
  • [72] A Vero Cell-Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies
    Fritz, Richard
    Sabarth, Nicolas
    Kiermayr, Stefan
    Hohenadl, Christine
    Howard, M. Keith
    Ilk, Reinhard
    Kistner, Otfried
    Ehrlich, Hartmut J.
    Barrett, P. Noel
    Kreil, Thomas R.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (01) : 28 - 34
  • [73] Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
    Galli, Grazia
    Hancock, Kathy
    Hoschler, Katja
    DeVos, Joshua
    Praus, Michaela
    Bardelli, Monia
    Malzone, Carmine
    Castellino, Flora
    Gentile, Chiara
    McNally, Teresa
    Del Giudice, Giuseppe
    Banzhoff, Angelika
    Brauer, Volker
    Montomoli, Emanuele
    Zambon, Maria
    Katz, Jacqueline
    Nicholson, Karl
    Stephenson, Iain
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (19) : 7962 - 7967
  • [74] Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
    Galli, Grazia
    Medini, Duccio
    Borgogni, Erica
    Zedda, Luisanna
    Bardelli, Monia
    Malzone, Carmine
    Nuti, Sandra
    Tavarini, Simona
    Sammicheli, Chiara
    Hilbert, Anne K.
    Brauer, Volker
    Banzhoff, Angelika
    Rappuoli, Rino
    Del Giudice, Giuseppe
    Castellino, Flora
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (10) : 3877 - 3882
  • [75] Development of a nanoparticle-based influenza vaccine using the PRINT® technology
    Galloway, Ashley L.
    Murphy, Andrew
    DeSimone, Joseph M.
    Di, Jie
    Herrmann, Jennifer P.
    Hunter, Michael E.
    Kindig, Jeffrey P.
    Malinoski, Frank J.
    Rumley, Megan A.
    Stoltz, Daria M.
    Templeman, Thomas S.
    Hubby, Bolyn
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2013, 9 (04) : 523 - 531
  • [76] Garrity RR, 1997, J IMMUNOL, V159, P279
  • [77] Inhaled Liposomes-Current Strategies and Future Challenges
    Gaspar, Maria Manuela
    Bakowsky, Udo
    Ehrhardt, Carsten
    [J]. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2008, 4 (03) : 245 - 257
  • [78] Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling
    Geeraedts, Felix
    Goutagny, Nadege
    Hornung, Veit
    Severa, Martina
    de Haan, Aalzen
    Pool, Judith
    Wilschut, Jan
    Fitzgerald, Katherine A.
    Huckriede, Anke
    [J]. PLOS PATHOGENS, 2008, 4 (08)
  • [79] The annual production cycle for influenza vaccine
    Gerdil, C
    [J]. VACCINE, 2003, 21 (16) : 1776 - 1779
  • [80] A Computationally Optimized Hemagglutinin Virus-Like Particle Vaccine Elicits Broadly Reactive Antibodies that Protect Nonhuman Primates from H5N1 Infection
    Giles, Brendan M.
    Crevar, Corey J.
    Carter, Donald M.
    Bissel, Stephanie J.
    Schultz-Cherry, Stacey
    Wiley, Clayton A.
    Ross, Ted M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (10) : 1562 - 1570
3456789101112